Cited 3 times in
Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 박지혜 | - |
dc.contributor.author | 천재희 | - |
dc.date.accessioned | 2022-12-22T03:44:11Z | - |
dc.date.available | 2022-12-22T03:44:11Z | - |
dc.date.issued | 2022-09 | - |
dc.identifier.issn | 1226-3303 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/191961 | - |
dc.description.abstract | The incidence and prevalence of inflammatory bowel diseases (IBDs) are rapidly increasing worldwide. IBDs are considered an emerging problem not only in Western countries but also in developing counties. The relapses and complications of active IBD mandate various medications. Nevertheless, hospitalization, emergency room visits, or surgery may be required, resulting in a socioeconomic burden. Great advances have been made in the development of new therapeutic options for IBD to achieve induction and maintenance remission. Nevertheless, conventional therapy is still the mainstay in the treatment of IBD. This review article provides an update on recent advances in conventional therapies, including 5-aminosalicylates, corticosteroids, immunomodulators, and anti-tumor necrosis factor-α agents to treat IBD. | - |
dc.description.statementOfResponsibility | open | - |
dc.language | English | - |
dc.publisher | Korean Association of Internal Medicine | - |
dc.relation.isPartOf | KOREAN JOURNAL OF INTERNAL MEDICINE | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Adrenal Cortex Hormones / adverse effects | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Immunologic Factors / adverse effects | - |
dc.subject.MESH | Inflammatory Bowel Diseases* / drug therapy | - |
dc.subject.MESH | Mesalamine* / adverse effects | - |
dc.subject.MESH | Tumor Necrosis Factor Inhibitors | - |
dc.subject.MESH | Tumor Necrosis Factor-alpha | - |
dc.title | Updates on conventional therapies for inflammatory bowel diseases: 5-aminosalicylates, corticosteroids, immunomodulators, and anti-TNF-α | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jihye Park | - |
dc.contributor.googleauthor | Jae Hee Cheon | - |
dc.identifier.doi | 10.3904/kjim.2022.132 | - |
dc.contributor.localId | A04575 | - |
dc.contributor.localId | A04030 | - |
dc.relation.journalcode | J02883 | - |
dc.identifier.eissn | 2005-6648 | - |
dc.identifier.pmid | 35882566 | - |
dc.subject.keyword | Adrenal cortex hormones | - |
dc.subject.keyword | Anti-TNF agents | - |
dc.subject.keyword | Immunologic factors | - |
dc.subject.keyword | Inflammatory bowel diseases | - |
dc.subject.keyword | Mesalamine | - |
dc.contributor.alternativeName | Park, Ji Hye | - |
dc.contributor.affiliatedAuthor | 박지혜 | - |
dc.contributor.affiliatedAuthor | 천재희 | - |
dc.citation.volume | 37 | - |
dc.citation.number | 5 | - |
dc.citation.startPage | 895 | - |
dc.citation.endPage | 905 | - |
dc.identifier.bibliographicCitation | KOREAN JOURNAL OF INTERNAL MEDICINE, Vol.37(5) : 895-905, 2022-09 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.